Literature DB >> 18537208

Effects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.

Junyong Zhang1, Donald S Thomas, Susan J Berners-Price, Nicholas Farrell.   

Abstract

Reported herein is a detailed study of the kinetics and mechanism of formation of a 1,4-GG interstrand cross-link by the dinuclear platinum anticancer compound [15N][{cis-PtCl(NH3)2}2{mu-NH2(CH2)6NH2}]2+ (1,1/c,c (1)). The reaction of [15N]1 with 5'-{d(ATATGTACATAT)2} (I) has been studied by [1H,15N] HSQC NMR spectroscopy in the presence of different concentrations of phosphate. In contrast with the geometric trans isomer (1,1/t,t), there was no evidence for an electrostatic preassociation of 1,1/c,c with the polyanionic DNA surface, and the pseudo-first-order rate constant for the aquation of [(15)N]1 was actually slightly higher (rather than lower) than that in the absence of DNA. When phosphate is absent, the overall rate of formation of the cross-link is quite similar for the two geometric isomers, occurring slightly faster for 1,1/t,t. A major difference in the DNA binding pathways is the observation of phosphate-bound intermediates only in the case of 1,1/c,c. 15 mM phosphate causes a dramatic slowing in the overall rate of formation of DNA interstrand cross-links due to both the slow formation and slow closure of the phosphate-bound monofunctional adduct. A comparison of the molecular models of the bifunctional adducts of the two isomers shows that helical distortion is minimal and globally the structures of the 1,4 interstrand cross-links are quite similar. The effect of carrier ligand was investigated by similar studies of the ethylenediamine derivative [15N]1-en. A pKa value of 5.43 was determined for the [15N]1,1/c,c-en diaquated species. The rate of reaction of [15N]1-en with duplex I is similar to that of 1,1/c,c and the overall conformation of the final adduct appears to be similar. The significance of these results to the development of "second-generation" polynuclear platinum clinical candidates based on the 1,1/c,c chelate (dach) series is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537208      PMCID: PMC2825901          DOI: 10.1002/chem.200800408

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  45 in total

1.  A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system.

Authors:  P Perego; C Caserini; L Gatti; N Carenini; S Romanelli; R Supino; D Colangelo; I Viano; R Leone; S Spinelli; G Pezzoni; C Manzotti; N Farrell; F Zunino
Journal:  Mol Pharmacol       Date:  1999-03       Impact factor: 4.436

2.  ERCC1 and clinical resistance to platinum-based therapy.

Authors:  Eddie Reed
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

Review 3.  Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

Authors:  E Reed
Journal:  Cancer Treat Rev       Date:  1998-10       Impact factor: 12.111

4.  Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA.

Authors:  M S Davies; S J Berners-Price; T W Hambley
Journal:  Inorg Chem       Date:  2000-12-11       Impact factor: 5.165

Review 5.  Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.

Authors:  P J McHugh; V J Spanswick; J A Hartley
Journal:  Lancet Oncol       Date:  2001-08       Impact factor: 41.316

6.  Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.

Authors:  Yun Qu; Neel J Scarsdale; My-Chau Tran; Nicholas P Farrell
Journal:  J Biol Inorg Chem       Date:  2002-07-31       Impact factor: 3.358

7.  Medium Effects on Reactivity Profiles for Platination of Phosphorothioate-Containing Oligonucleotides.

Authors:  Johan Kjellström; Sofi K. C. Elmroth
Journal:  Inorg Chem       Date:  1999-12-27       Impact factor: 5.165

8.  Circular dichroism study of the irreversibility of conformational changes induced by polyamine-linked dinuclear platinum compounds.

Authors:  Tracey D McGregor; Wendi Bousfield; Yun Qu; Nicholas Farrell
Journal:  J Inorg Biochem       Date:  2002-07-25       Impact factor: 4.155

9.  Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.

Authors:  Alexander Hegmans; Susan J Berners-Price; Murray S Davies; Donald S Thomas; Anthony S Humphreys; Nicholas Farrell
Journal:  J Am Chem Soc       Date:  2004-02-25       Impact factor: 15.419

10.  HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.

Authors:  J C Huang; D B Zamble; J T Reardon; S J Lippard; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

View more
  4 in total

1.  Competitive formation of both long-range 5'-5' and short-range antiparallel 3'-3' DNA interstrand cross-links by a trinuclear platinum complex on binding to a 10-mer duplex.

Authors:  Rasha A Ruhayel; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2012-11-19       Impact factor: 4.390

2.  Solution studies of dinuclear polyamine-linked platinum-based antitumour complexes.

Authors:  Rasha A Ruhayel; Ibrahim Zgani; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2011-03-08       Impact factor: 4.390

3.  Dinuclear platinum complexes containing planar aromatic ligands to enhance stacking interactions with proteins.

Authors:  Erin S F Ma; A Gerard Daniel; Nicholas P Farrell
Journal:  ChemMedChem       Date:  2014-05-06       Impact factor: 3.466

4.  Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

Authors:  Lenka Zerzankova; Tereza Suchankova; Oldrich Vrana; Nicholas P Farrell; Viktor Brabec; Jana Kasparkova
Journal:  Biochem Pharmacol       Date:  2009-08-12       Impact factor: 5.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.